JD
Therapeutic Areas
CMP Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Norliqva® (Amlodipine Oral Solution) | Hypertension | Approved |
| Tadliq® (Tadalafil Oral Suspension) | Pulmonary Arterial Hypertension | Approved |
| Atorvastatin Oral Liquid Suspension | Hypercholesterolemia | Approved |
| CaroSpir® (Spironolactone Oral Suspension) | Heart Failure, Edema, Hypertension | Approved |
| SPS® Suspension (Sodium Polystyrene Sulfonate) | Hyperkalemia | Approved |
| Isoniazid Oral Solution, USP | Tuberculosis | Approved |
| Oracit® | Metabolic Acidosis | Approved |
| Absorbase® | Contact Dermatitis | Approved |